Diplon, Monica T.

HRN: 10-01-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/17/2022
05/23/2022
IVT
4.5g
Q6
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: